Perfusion bioreactor-based cryopreservation of 3D human mesenchymal stromal cell tissue grafts
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články
PubMed
28395973
DOI
10.1016/j.cryobiol.2017.04.001
PII: S0011-2240(17)30075-5
Knihovny.cz E-zdroje
- Klíčová slova
- Cryopreservation, DMSO, Engineered tissue graft, Me(2)SO, Mesenchymal stromal cells, Tissue engineering,
- MeSH
- bioreaktory MeSH
- kryoprezervace metody MeSH
- kryoprotektivní látky farmakologie MeSH
- lidé MeSH
- mezenchymální kmenové buňky * MeSH
- perfuze MeSH
- tkáňové inženýrství metody MeSH
- viabilita buněk účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- kryoprotektivní látky MeSH
The generation of an off-the-shelf in vitro engineered living tissue graft will likely require cryopreservation. However, the efficient addition and removal of cryoprotective agents (CPA) to cells throughout the volume of a three-dimensional (3D) tissue graft remains a significant challenge. In this work, we assessed whether a perfusion bioreactor-based method could be used to improve the viability of cryopreserved mesenchymal stromal cell- (MSC) based tissue constructs as compared to using conventional diffusion-based methods. The bioreactor was first used to saturate 3D constructs with CPA under perfused flow. Following cryopreservation, the bioreactor was then also used for the efficient removal of the CPA from the 3D tissues. We demonstrate that addition and removal of CPA under perfused flow significantly increased the viability of MSC within cryopreserved 3D tissue constructs as compared to conventional diffusion-based methods.
Citace poskytuje Crossref.org